Harvard T.H. Chan School of Public Health, Boston, MA
BA, Human Biology
Claremont McKenna College, Claremont, CA
Alison Tse Kawai is a Senior Research Epidemiologist at RTI-HS. Dr. Kawai has more than 10 years’ experience as a pharmacoepidemiologist. She is experienced in planning, designing, and implementing large, multisite database studies for post authorization safety studies in the United States and Europe. Dr. Kawai has worked with data from electronic health records, claims, medical record validation, and public health registries. She has conducted studies in a range of settings, including distributed databases with common data models. She has experience in a range of therapeutic and disease areas, with expertise in vaccine safety and in pregnancy safety studies.
Before coming to RTI-HS, Dr. Kawai was a Research Scientist and Principal Associate in the Department of Population Medicine at Harvard Pilgrim Health Care Institute and Harvard Medical School, where she was an investigator within the Sentinel Program and the Vaccine Safety Datalink Project, two federally-funded postmarket safety surveillance systems that incorporate data from several health insurers across the US with the use of distributed databases. While there, she worked primarily on studies to evaluate vaccine safety in pregnant women and pediatric populations, as well as on infrastructure activities to develop methods and data capabilities to conduct these and other postmarketing safety studies. Dr. Kawai received her master’s and doctorate degrees from the Harvard Chan School of Public Health.